Subsensitivity of adenylyl cyclase-coupled receptors on mononuclear leukocytes from drug-free inpatients with a major depressive episode

Biological Psychiatry

Volumn 42, Issue 10, 1997, Pages 859-870

  Mann, J John ^a,d   Halper, James P ^b   Wilner, Philip J ^b   Sweeney, John A ^c   Mieczkowski, Tammy A ^c   Chen, Jaw Sy ^b   Stokes, Peter E ^b   Brown, Richard P ^a  

^a The New York Presbyterian Hospital   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Adenylyl cyclase; Beta adrenergic; Catecholamines; Leukocytes; Major depression

Indexed keywords

ADENYLATE CYCLASE; ADRENALIN; ALPRAZOLAM; BETA ADRENERGIC RECEPTOR; CODEINE; CYCLIC AMP; FORSKOLIN; HYDROCORTISONE; ISOPRENALINE; METOCLOPRAMIDE; NORADRENALIN; PARACETAMOL; PROSTAGLANDIN RECEPTOR; TRAZODONE;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DESENSITIZATION; FEMALE; HAMILTON SCALE; HOSPITAL PATIENT; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; THIN LAYER CHROMATOGRAPHY;

ADENYLATE CYCLASE; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ADULT; AGE DISTRIBUTION; AGED; CATECHOLAMINES; CYCLIC AMP; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROCORTISONE; ISOPROTERENOL; LEUKOCYTES; MALE; MIDDLE AGED; PLASMA; PROSTAGLANDINS; PSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 0030695927     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00154-6     Document Type: Article

References (62)

1. 2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038-1047.
2. Aronson TA, Carasiti I, McBane D, Whitaker-Azmitia P (1989): Biological correlates of lactate sensitivity in panic disorder. Biol Psychiatry 26:463-477.
3. Avissar S, Barki-Harrington L, Nechamkin Y, Roitman G, Schreiber G (1996): Reduced β-adrenergic receptor-coupled Gs protein function and Gsα immunoreactivity in mononuclear leukocytes of patients with depression. Biol Psychiatry 39:755-760.
4. Bertschy G, Vandel S, Puech A, Vandel B, Sandoz M, Allers G (1989): Cardiac beta-adrenergic sensitivity in depression: Relation with endogenous subtype and desipramine response. Neuropsychobiology 21:177-181.
5. Boyum A (1968): Isolation of mononuclear cells and glanulocytes from human blood: Isolation of mononuclear cells by centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest 97:77-79.
6. Brown BL, Albano JD, Ekins RP, Sghevzi AM, Tampoin W (1971): A simple and sensitive saturation assay method for the measurement of adenosine 3,5-cyclic monophosphate. Biochem J 121:561-562.
7. Brown RP, Stoll PM, Stokes PE, Frances A, Sweeney J, Kocsis JH, et al (1987): Adrenocortical hyperactivity in depression: Effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res 23:167-178.
8. Brown SL, Charney DS, Woods SW, Heninger GR, Tallman J (1988): Lymphocyte beta-adrenergic receptor binder in panic disorder. Psychopharmacology 94:24-28.
9. Buckholtz NS, Davies AO, Rudorfer MV, Golden RN, Potter WZ (1988): Lymphocyte beta adrenergic receptor function versus catecholamines in depression. Biol Psychiatry 24:451-457.
10. Carstens ME, Engelbrecht AH, Russell VA, Aalbers C, Gagiano CA, Chalton DO, et al (1986): Beta-adrenoceptors on lymphocytes of patients with major depressive disorder. Psychiatry Res 20:239-248.
11. s) and adenylyl cyclase. J Neurochem 64:724-732.
12. Cowburn RF, Marcusson JO, Eriksson A, Wiehager B, O'Neill C (1994): Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res 633:297-304.
13. Davies AO, Lefkowitz RJ (1980): Corticosteroid-induced differential regulation of B-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab 51:599-605.
14. Davies AO, Lefkowitz RJ (1981): Agonist-promoted high affinity state of the B-adrenergic receptor in human neutrophils: Modulation by corticosteroids. J Clin Endocrinol Metab 53:703-708.
15. Davies AO, Lefkowitz RJ (1983): In vitro desensitization of beta-adrenergic receptors in human neutrophils: Attenuation by corticosteroids. J Clin Invest 71:565-571.
16. Davies AO, DeLean A, Lefkowitz RJ (1981): Myocardial beta-adrenergic receptors from adrenalectomized rats: Impaired formation of high affinity agonist-receptor complexes. Endocrinology 108:720-722.
17. Ebstein RP, Mintzer J, Lipshitz I, Shemesh Z, Slessman J (1986): Hormone and forskolin-stimulated cyclic AMP accumulation in human leukocytes: Reliability of longitudinal time measurements. Experimentia 42:838-841.
18. Ebstein RP, Lerer B, Shapira B, Shemesh Z, Moscovich DG, Kindler S (1988): Cyclic AMP second-messenger signal amplification in depression. Br J Psychiatry 152:665-669.
19. Extein I, Tallman J, Smith CC, Goodwin FK (1979): Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiatry Res 1:191-197.
20. Feldman RD, Limbird LE, Nadeau J, Fitzgerald GA, Robertson D, Wood AJJ (1983): Dynamic regulation of leukocyte beta adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines. J Clin Invest 72:164-170.
21. Ferrier IN, McKeith IG, Cross AJ, Perry EK, Candy JM, Perry RH (1986): Postmortem neurochemical studies in depression. Ann NY Acad Sci 487:128-142.
22. Foster SJ, Harden TK (1980): Dexamethasone increases B-adrenoceptor density in human astrocytoma cells. Biochem Pharmacol 29:2151-2153.
23. Garver DL, Johnson C, Kanter DR (1982): Schizophrenia and reduced cyclic AMP production: Evidence for the role of receptor-linked events. Life Sci 31:1987-1992.
24. 2-adrenoreceptors in depression: A critical examination. J Psychopharmacol 7:4-18.
25. Halper JP, Brown RP, Sweeney JA, Kocsis JH, Peters A, Mann JJ (1988): Blunted β-adrenergic responsivity of peripheral blood mononuclear cells in endogenous depression. Arch Gen Psychiatry 45:241-244.
26. Insel PA, Motulsky HJ, Mahan LC (1985): Regulation of cyclic AMP accumulation in lymphoid cells (42125). Proc Soc Exp Biol Med 179:472-478.
27. Jeanningros R, Mazzola P, Azorin JM, Samuelian-Massa C, Tissot R (1991): β-Adrenoceptor density of intact mononuclear leukocytes in subgroups of depressive disorders. Biol Psychiatry 29:789-798.
28. Kafka MS, van Kammen DP (1983): α-Adrenergic receptor function in schizophrenia. Receptor number, cyclic adenosine monophosphate production, adenylate cyclase activity, and effect of drugs. Arch Gen Psychiatry 40:264-270.
29. Kaiya H, Ofuji M, Nozaki M, Tsurumi K (1990): Platelet prostaglandin E hyposensitivity in schizophrenia: Decrease in cyclic AMP formation and in inhibitory effects on aggrega-tion. Psychopharmacol Bull 26:3:381-384.
30. Kanof PD, Johns C, Davidson M, Siever LJ, Coccaro EF, Davis KL (1986): Prostaglandin receptor sensitivity in psychiatric disorders. Arch Gen Psychiatry 43:987-993.
31. Klysner R, Geisler A, Rosenberg R (1987): Enhanced histamine- and beta-adrenergic-mediated cyclic AMP formulation in leukocytes from patients with endogenous depression. J Affect Disord 13:227-232.
32. Lefkowitz RJ, Caron MG, Stiles GL (1984): Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors. N Engl J Med 310:1570-1579.
33. Magliozzi JR, Gietzen D, Maddock RJ, Haack D, Doran AR, Goodman T, et al (1989): Lymphocyte beta-adrenoreceptor density in patients with unipolar depression and normal controls. Biol Psychiatry 26:15-25.
34. Manji HK, Potter WZ, Lenox RH (1995): Signal transduction pathways. Arch Gen Psychiatry 52:531-543.
35. Mann JJ, Brown RP, Halper JP, Sweeney JA, Kocsis JH, Stokes PE, et al (1985): Reduced sensitivity of lymphocyte β-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med 313:715-720.
36. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954-959.
37. Mann JJ, Mahler JC, Wilner PJ, Halper JP, Brown RP, Johnson KS, et al (1990): Normalization of blunted lymphocyte β-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy. Arch Gen Psychiatry 47:461-464.
38. 1-adrenoceptors. Eur J Pharmacol 87:35-41.
39. Milligan G (1993): Agonist regulation of cellular G protein levels and distribution: Mechanisms and functional implications. Trends Pharmacol Sci 14:413-418.
40. Mooney JJ, Schatzberg AF Cole JO, Kizuka PP, Schildkraut JJ (1985): Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: Preliminary data. J Psvchiatr Res 19:65-75.
41. Murphy DL, Donnelly C, Moskowitz J (1974): Catecholamine receptor function in depressed patients. Am J Psychiatry 131:1389-1391.
42. s to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol 36:803-808.
43. s to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 56:330-338.
44. Pandey GN, Dysken MW, Garver DL, Davis JM (1979a): Beta-adrenergic receptor function in affective illness. Am J Psychiatry 136:675-678.
45. Pandey GN, Heinze WJ, Brown BD, Davis JM (1979b): Electroconvulsive shock treatment decreases β-adrenergic receptor sensitivity in rat brain. Nature 280:234-235.
46. Pandey GN, Janicak PG, Davis J (1987): Decreased beta-adrenergic receptors in the leukocytes of depressed patients. Psychiatry Res 22:265-273.
47. Patten JL, Johns DR, Valle D, Eil C Gruppuso PA, Steele G, et al (1990): Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 322:1412-1462.
48. Peuler JD, Johnson GA (1977): Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci 21:625-636.
49. Redmond DE, Katz MM, Maas JW, Swann A, Casper R, Davis JM (1986): Cerebrospinal fluid amine metabolites. Arch Gen Psychiatry 43:938-947.
50. Robins E, Murphy GE, Wilkinso RH, Gessner F, Kayes J (1979): Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. Am J Public Health 49:888-899.
51. Rotrosen J, Miller AD, Mandio D, Traficante LJ, Gershon S (1980): Prostaglandins, platelets, and schizophrenia. Arch Gen Psychiatry 37:1047-1054.
52. Seaman K, Daly JW (1981): Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem 256:9799-9801.
53. Seaman KB, Daly JW (1986): Forskolin: Its biological and chemical properties. In: Greengard P, Robison GA, editors. Advances in Cyclic Nucleotide and Protein Phosphorylation Research. New York: Raven Press, pp 1-150.
54. Siever LJ, Kafka MS, Targum S, Lake CR (1984): Platelet alpha-adrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatry Res 11:287-302.
55. Smith TJ, Dana R, Krichevsky A, Bilezikian JP, Schonberg M (1981): Inhibition of β-adrenergic responsiveness in muscle cell cultures by dexamethasone. Endocrinology 109:2110-2116.
56. Spitzer RL, Williams JBW, Gibbon M, First MB (1992): The structured clinical interview for DSM-III-R (SCID): I. History, rationale, and description. Arch Gen Psychiatry 49:624-629.
57. Stiles GL, Caron MG, Lefkowitz RJ (1984): β-Adrenergic receptors: Biochemical mechanisms of physiological regulation. Physiol Rev 64:661-743.
58. Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, et al (1984): Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Arch Gen Psychiatry 41:257-267.
59. Sulser F, Gillespie DD, Mishra R, Manier DH (1984): Desensitization by antidepressants of central norepinephrine receptor systems coupled to adenylate cyclase. Ann NY Acad Sci 430:91-101.
60. Wang Y-C, Pandey GN, Mendels J, Frazer A (1974): Platelet adenylate cyclase responses in depression: Implications for a receptor defect. Psychopharmacology (Berl) 36:291-300.
61. Wilner PJ, Brown RP, Halper JP, Johnson KS, Sweeney JA, Chen J-S. et al (in press): Plasma catecholamines in major depression: Relationship to clinical subtypes, symptoms, cardiovascular measures and adrenocortical dysfunction. Arch Gen Psychiatry.
62. s α-subunit levels are elevated in bipolar affective disorder. Brain Res 553:323-326.